Fabupharm is a Namibian pharmaceutical company that prioritizes health and well-being with its diverse range of products, including paracetamol, antibiotics, vitamin supplements, and sunscreen. Established in 1989, the company has been dedicated to providing trusted pharmaceutical solutions. Its recent Venture Round investment in 05 September 2016 was backed by Eos Capital, reflecting the confidence of investors in Fabupharm's mission. Operating at the intersection of Health Care, Manufacturing, and Pharmaceutical industries, Fabupharm continues to be a significant player in the Namibian healthcare sector.
General Information
BounceWatch is an independent company data service, not affiliated with Fabupharm. To contact Fabupharm, visit fabupharmnamibia.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Fabupharm compare?
A PDF of Fabupharm and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Fabupharm soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Fabupharm
Business keywords: pharmaceutical manufacturing, healthcare products, Namibian pharmaceuticals, health and well-being, paracetamol, antibiotics, vitamin supplements, sunscreen, local manufacturing, trusted products
Funding Rounds & Investors (1)
View AllFabupharm Alternatives & Competitors
View All AlternativesThrough science we harness the properties of nature to improve people's health and well-being.
Maximum Care for Better Health
FAQ About Fabupharm
Source: BounceWatch company record for Fabupharm, https://bouncewatch.com/company/fabupharm, updated 11 September 2024. When citing, please name BounceWatch and link this page.